Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05020496
EARLY_PHASE1

Trem-1 and Ultraviolet Radiation-induced Immune Suppression

Sponsor: University of Alabama at Birmingham

View on ClinicalTrials.gov

Summary

The overall goal of this study is to determine novel mechanisms for ultraviolet light (UV)-induced suppression of the immune system in human subjects and to improve understanding of UV-induced skin carcinogenesis.

Official title: Role of Trem-1 in Ultraviolet Radiation-induced Immune Suppression

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

70

Start Date

2022-03-21

Completion Date

2026-10-01

Last Updated

2025-06-29

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Diphenylcyclopropenone (DPCP)

Drug will be applied topically on the skin. It will cause contact hypersensitivity in patients

Locations (1)

Whitaker Clinic

Birmingham, Alabama, United States